These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17983240)

  • 1. Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif.
    Daniels DS; Schepartz A
    J Am Chem Soc; 2007 Nov; 129(47):14578-9. PubMed ID: 17983240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally cationic cell-permeable miniature proteins via alpha-helical arginine display.
    Smith BA; Daniels DS; Coplin AE; Jordan GE; McGregor LM; Schepartz A
    J Am Chem Soc; 2008 Mar; 130(10):2948-9. PubMed ID: 18271592
    [No Abstract]   [Full Text] [Related]  

  • 3. The structure of "unstructured" regions in peptides and proteins: role of the polyproline II helix in protein folding and recognition.
    Rath A; Davidson AR; Deber CM
    Biopolymers; 2005; 80(2-3):179-85. PubMed ID: 15700296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyproline II structure in proteins: identification by chiroptical spectroscopies, stability, and functions.
    Bochicchio B; Tamburro AM
    Chirality; 2002 Nov; 14(10):782-92. PubMed ID: 12395395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying the uptake of cell-penetrating peptides.
    Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
    Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a human estrogen receptor alpha-derived antiestrogenic peptide that adopts a polyproline II conformation.
    Kapitán J; Gallo D; Goasdoué N; Nicaise M; Desmadril M; Hecht L; Leclercq G; Barron LD; Jacquot Y
    J Pept Sci; 2009 Jul; 15(7):455-64. PubMed ID: 19424961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic amphiphilic polyproline helices: side-chain variations and cell-specific internalization.
    Geisler I; Chmielewski J
    Chem Biol Drug Des; 2009 Jan; 73(1):39-45. PubMed ID: 19152633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
    Ziegler A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyproline II helical structure in protein unfolded states: lysine peptides revisited.
    Rucker AL; Creamer TP
    Protein Sci; 2002 Apr; 11(4):980-5. PubMed ID: 11910041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Required structure of cationic peptide for oligonucleotide-binding and -delivering into cells.
    Niidome T; Wakamatsu M; Wada A; Hirayama T; Aoyagi H
    J Pept Sci; 2000 Jun; 6(6):271-9. PubMed ID: 10912907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell penetrating agents based on a polyproline helix scaffold.
    Fillon YA; Anderson JP; Chmielewski J
    J Am Chem Soc; 2005 Aug; 127(33):11798-803. PubMed ID: 16104758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proline-rich, amphipathic cell-penetrating peptides.
    Pujals S; Giralt E
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left-helical (PPII-PPII) type of globular protein structure: the level of the left helical type of poly-L-proline II in Kunitz trypsin inhibitor is no less than 43%. Experimental Reper spectrum of the extended left helix].
    Bazhulina NP; Korolev SV; Morozov NIu; Rogulenkova VN; Esipova NG
    Biofizika; 1994; 39(4):746-8. PubMed ID: 7981285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
    Zorko M; Langel U
    Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.